Answers are grounded in this paper and cite their sources.
In 2020, Brazil joined Pharmaceutical Pricing and Reimbursement Information (PPRI). PPRI is a network of public authorities responsible for pharmaceutical pricing and reimbursement policies from 50, mainly European, countries. It offers a platform to its members to share information and experiences regarding pricing and reimbursement policies for medicines, and this helps improve access to affordable medicines. Information-sharing is done, among others, through network queries, country reports, meetings and webinars. Contributing to the PPRI network activities, Brazil can benefit from the policy experience of the other countries.
No takes yet. Share an insight, caveat, or question.
Vogler et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: